Case 38-2010: A 13-year-old girl with an enlarging neck mass

New England Journal of Medicine

Volumn 363, Issue 25, 2010, Pages 2445-2454

  Misra, Madhusmita ^a,b   Parangi, Sareh ^a,b   Ross, Douglas S ^a,b   Shailam, Randheer ^a,b   Sadow, Peter M ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; LIOTHYRONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; GOITER; HISTOPATHOLOGY; HUMAN; LIOTHYRONINE BLOOD LEVEL; MEDICAL HISTORY; NECK TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYROID CANCER; THYROID GLAND EXAMINATION; THYROID NODULE; THYROIDITIS; THYROTROPIN BLOOD LEVEL;

EID: 78650192160     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1004361     Document Type: Article

References (40)

1. LaFranchi S. Goiter and thyroid cancer in children. (http://www.uptodate. com/home/index.html.)
2. Corrias A, Cassio A, Weber G, et al. Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med 2008;162:526-31. (Pubitemid 351786952)
3. Hung W. Solitary thyroid nodules in 93 children and adolescents: a 35-years experience. Horm Res 1999;52:15-8. (Pubitemid 30071923)
4. Kirkland RT, Kirkland JL, Rosenberg HS, Harberg FJ, Librik L, Clayton GW. Solitary thyroid nodules in 30 children and report of a child with a thyroid abscess. Pediatrics 1973;51:85-90.
5. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91:4295-301. (Pubitemid 44833401)
6. Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World J Surg 2009;33:958-62.
7. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623-39.
8. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996;28:25-32.
9. Kwak JY, Kim EK, Son EJ, et al. Papillary thyroid carcinoma manifested solely as microcalcifications on sonography. AJR Am J Roentgenol 2007;189:227-31.
10. Milas M, Stephen A, Berber E, Wagner K, Miskulin J, Siperstein A. Ultrasonography for the endocrine surgeon: a valuable clinical tool that enhances diagnostic and therapeutic outcomes. Surgery 2005;138:1193-201.
11. Schlosser K, Zeuner M, Wagner M, et al. Laryngoscopy in thyroid surgery - essential standard or unnecessary routine? Surgery 2007;142:858-64. [Erratum, Surgery 2008;143:302.]
12. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
13. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-84.
14. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007;142:906-13. [Erratum, Surgery 2008;143:302.]
15. Sadowski BM, Snyder SK, Lairmore TC. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 2009;146:696-705.
16. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214. [Errata, Thyroid 2010;20:674-5, 942.]
17. Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19:1153-8.
18. Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004;136:1310-22.
19. Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Complications of neck dissection for thyroid cancer. World J Surg 2002;26:1013-6.
20. Dralle H, Machens A. Surgical approaches in thyroid cancer and lymphnode metastases. Best Pract Res Clin Endocrinol Metab 2008;22:971-87.
21. Yarbrough DE, Thompson GB, Kasperbauer JL, Harper CM, Grant CS. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery 2004;136:1107-15.
22. Sierra M, Herrera MF, Herrero B, et al. Prospective biochemical and scintigraphic evaluation of autografted normal parathyroid glands in patients undergoing thyroid operations. Surgery 1998;124:1005-10.
23. Mekel M, Stephen AE, Gaz RD, et al. Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancer. Am J Surg 2010;199:485-90.
24. Ito Y, Miyauchi A. Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg 2008;32:729-39.
25. Wada N, Masudo K, Nakayama H, et al. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 2008;34:202-7.
26. Bai Y, Zhou G, Nakamura M, et al. Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol 2009;22:887-94.
27. Das DK. Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? Diagn Cytopathol 2009;37:534-41.
28. Thyroid. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York: Springer, 2009:87-96.
29. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press, 2004.
30. Bongiovanni M, Triponez F, McKee TA, Kumar N, Matthes T, Meyer P. Fineneedle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis: a potential pitfall: a case report and review of the literature. Diagn Cytopathol 2009;37:671-5.
31. Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL. BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 2006;17:235-41.
32. Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW. Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 2007;20:779-87. (Pubitemid 46933449)
33. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545-76.
34. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-30.
35. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-8.
36. Chow SM, Chan JK, Law SC, et al. Diffuse sclerosing variant of papillary thyroid carcinoma - clinical features and outcome. Eur J Surg Oncol 2003;29:446-9.
37. Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 2006;13:176-81.
38. Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E. Prognostic importance of sclerosing variant in papillary thyroid carcinoma. Am Surg 2006;72:438-44.
39. Pacini F, Ladenson PW, Schlumberger M, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 2006;91:926-32.
40. Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006;16:1229-42.